研究论文

利用新型氮烷基化方法合成抗组胺药物羟嗪

  • 董宏波 ,
  • 郑登宇 ,
  • 罗红兵 ,
  • 杜伟宏 ,
  • 林家富 ,
  • 曹胜华
展开
  • a 成都大学四川抗菌素工业研究所 药食同源植物资源开发四川省高校重点实验室 成都 610052;
    b 成都大学四川抗菌素工业研究所 抗生素研究与再评价四川省重点实验室 成都 610052

收稿日期: 2016-04-29

  修回日期: 2016-05-26

  网络出版日期: 2016-07-07

基金资助

抗生素研究与再评价四川省重点实验室开放基金(No.ARRLKF14-09)资助项目.

Synthesis of Antihistamine Drug Hydroxyzine with New N-Alkylation Method

  • Dong Hongbo ,
  • Zheng Dengyu ,
  • Luo Hongbing ,
  • Du Weihong ,
  • Lin Jiafu ,
  • Cao Shenghua
Expand
  • a Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610052;
    b Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610052

Received date: 2016-04-29

  Revised date: 2016-05-26

  Online published: 2016-07-07

Supported by

Project supported by the Open Foundation of Antibioticis Research and Re-evaluation Key Laboratory of Sichuan Province (No.ARRLKF14-09).

摘要

首次报道了利用Raney-Ni催化的氮烷基化方法合成了抗组胺药物羟嗪(Hydroxyzine,1a),在此基础上优化反应条件,对底物进行拓展,成功合成14个二苯甲基哌嗪类化合物,其中包括抗组胺药物去氯羟嗪(Decloxizine,1j)、美克洛嗪(Meclizine,1l)、布克利嗪(Buclizine,1m)与钙离子通道阻滞剂洛美利嗪(Lomerizine,1n),为此方法在这些药物上的首次应用,提高了其在药物合成方面的应用价值.

本文引用格式

董宏波 , 郑登宇 , 罗红兵 , 杜伟宏 , 林家富 , 曹胜华 . 利用新型氮烷基化方法合成抗组胺药物羟嗪[J]. 有机化学, 2016 , 36(11) : 2709 -2714 . DOI: 10.6023/cjoc201604060

Abstract

The Raney-Ni catalyzed N-alkylation for the synthesis of antihistamine drug hydroxyzine (1a) has been developed. The substrate scope was expanded with the optimized reaction conditions, and fourteen diphenylmethyl piperazine derivatives including antihistamine drugs decloxizine (1j), mecilizine (1l), buclizine (1m) and calcium channel blocker lomerizine (1n) were successfully prepared. This Raney-Ni catalyzed N-alkylation was the first protocol that applied in these drugs synthesis. And this research improve its application value in drug synthesis.

参考文献

[1] Snowman, A. M.; Snyder, S. H. J. Allergyry Clin. Immunol. 1990, 86, 1025.
[2] Llorca, P. M.; Spadone, C.; Sol, O. J. Clin. Psychiatry 2002, 63, 1020.
[3] Irikura, T.; Masuzawa, K.; Nishino, K.; Kitagawa, M.; Uchida, H.; Ichinoseki, N.; Masatoshi, I. M. J.Med. Chem. 1986, 11, 801.
[4] Yang, Q.; Wang, Q.; Yu, Z. Chem. Soc. Rev. 2015, 46, 2305.
[5] Banerjee, D.; Jagadeesh, R. V.; Junge, K.; Junge, H.; Belle, M. ChemSusChem 2012, 5, 2039.
[6] Banerjee, D.; Jagadeesh, R. V.; Junge, K.; Pohl, M.; Radnik, J. Angew. Chem., Int. Ed. 2014, 53, 4359.
[7] Martinez-Asencio, A.; Yus, M.; Ramon, D. J. Synthesis 2011, 43, 3730.
[8] Hamid, M. H. S. A.; Allen, C. L.; Lamb, G. W.; Maxwell, A. C.; Maytum, H. C.; Watson, A. J. A.; Williams, J. M. J. J. Am. Chem. Soc. 2009, 131, 1766.
[9] Watson, A. J. A.; Maxwell, A. C.; Williams, J. M. J. J. Am. Chem. Soc. 2007, 76, 2328.
[10] Prades, A.; Corberan, R.; Poyatos, M.; Peris, E. Chem. Eur. J. 2008, 40, 11474.
[11] Bartoszewicz, A.; Marcos, R.; Sahoo, S.; Inge, A. K.; Zou, X.; Martin-Matute, B. Chem. Eur. J. 2012, 18, 14510.
[12] Li, F.; Shan, H. X.; Kang, Q. K.; Chen, L. Chem. Commun. 2011, 47, 5058.
[13] Martinez, R.; Ramon, D. J.; Yus, M. Org. Biomol. Chem. 2009, 40, 2176.
[14] Shimizu, K.; Imaiida, N.; Kon, K.; Hakim, S. S. M. A.; Satsuma, A. ACS Catal. 2013, 3, 998.
[15] Garcia, R. J. L.; Parra, A.; Aleman, J.; Yusteb, F.; Mastranzob, V. M. Chem. Commun. 2009, 80, 404.
[16] Mehta, A.; Thaker, A.; Londhe, V.; Santosh, R. N. Appl. Catal. A, Gen. 2014, 478, 241.
[17] Xu, Q.; Li, Q. Chin. J. Org. Chem. 2013, 33, 18 (in Chinese). (徐清, 李强, 有机化学, 2013, 33, 18.)
[18] Venkat, N. A.; Narsimha, P. Med. Chem. Res. 2012, 21, 538.
[19] Bansi, L.; Sanjoy, L.; Prabhakar, B. C.; Suresh, K. R.; Kasam, M. D.; Yasin, H. A. WO 2010046908, 2010[Chem. Abstr. 2010, 152, 501410].
[20] Narsaiah, A. V.; Kumar, J. K. Synthesis 2010, 1989.

文章导航

/